Product
Prolonged glucocorticosteroid
1 clinical trial
2 indications
Indication
Lung CancerIndication
Interstitial Lung DiseaseClinical trial
Randomized Open-label Study of the Impact of Prolonged Systemic Corticosteroid Therapy on the Course and Relapse Risk of Checkpoint Inhibitor Interstitial Lung Disease (Pneumonitis) Related to the Treatment of Solid Tumors With Anti-programmed-death Type 1 Receptor or Ligand AntibodiesStatus: , Estimated PCD: 2024-02-01